Has Jacqlyn Whitby received payments from drug or device companies?

Yes. Drug and device makers reported $2,081 in general payments to Jacqlyn Whitby across 132 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jacqlyn Whitby did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jacqlyn Whitby come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jacqlyn Whitby

Acute Care · Haddon Heights, NJNPI 1982317012

Payments from drug & device makers

$2,081in general payments, 2019–2025

Across 132 payments — averaging $15.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Novartis$592
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$232
Amgen$166
Pfizer$158
Abbott$128
Merck$126
plus $680 from 15 others

What the payments were for

Food & beverage$2,081100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Novartis	58	$592
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	7	$232
Amgen	10	$166
Pfizer	10	$158
Abbott	2	$128
Merck	8	$126
Johnson & Johnson	7	$123
Atricure, Inc.	3	$109
Bayer	4	$69
Kiniksa Pharmaceuticals, Ltd.	3	$50
Daiichi Sankyo Inc.	3	$46
Kiniksa Pharmaceuticals International, PLC	3	$46
Kestra Medical Technology Services, Inc.	3	$44
Edwards Lifesciences	2	$42
Regeneron Healthcare Solutions, Inc.	2	$37
AstraZeneca	2	$28
Heartflow, Inc.	1	$21
GSK	1	$18
Bridgebio Pharma, Inc.	1	$17
Actelion Pharmaceuticals US, Inc.	1	$16
Esperion Therapeutics, Inc.	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Perclose ProStyle$106

How this compares

$2,081 in reported general payments places this provider in the 85th percentile of 656 acute care providers in New Jersey.

See all acute care providers in New Jersey →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	427	$600,602
XareltoRivaroxaban	131	$166,355
EntrestoSacubitril/Valsartan	65	$90,081
FarxigaDapagliflozin Propanediol	31	$39,039
Repatha SureclickEvolocumab	27	$36,897
Metoprolol Succinate	601	$11,253
Atorvastatin Calcium	360	$4,746
Valsartan	115	$3,633
Rosuvastatin Calcium	168	$3,528
Diltiazem 24hr Er (Cd)Diltiazem Hcl	86	$3,377
Ranolazine ErRanolazine	14	$2,736
Flecainide Acetate	42	$2,584
Carvedilol	232	$2,318
Losartan Potassium	196	$2,032
Furosemide	315	$2,026

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
PfizerEliquis	$158	$600,602427 claims
Johnson & JohnsonXarelto	$123	$166,355131 claims
NovartisEntresto	$592	$90,08165 claims
AstraZenecaFarxiga	$28	$39,03931 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 656 acute care providers in New Jersey.

Other acute care in Haddon Heights

Gabriella MagarelliHackensack$44K
Per RosenkvistLivingston$29K
Matthew OstroffPaterson$27K
Ellen McCueNeptune$26K
Suzanne ShuggLivingston$25K
Maria Tedi CoronelHackensack$19K
Hanane ChaibainouWestampton$16K
Jennifer McCarthyNewark$16K
Jennifer HarrarCamden$16K
Vincent FroncekFlemington$14K

See the full list for New Jersey →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →